BAJAJ FINSERV DIRECT LIMITED
Open Your FREE Demat Account Now!

Ambani Orgochem Ltd. Share Price

NSE
BSE

NSE : AMBANIORGO

BSE : 0

Sector : Chemicals

N/A
indicator
1D
1M
3M
6M
1Y
5Y
empty graph

Day's Range

Day's Range

Low

High

Financials

Particulars QTR FY (₹ in Millions) Annual FY (₹ in Millions)
Net sales N/A 1939.28
Expenses N/A N/A
PBT N/A 3.6
Operating profit N/A 0.0
Net profit N/A -9.21

Shareholding Pattern

Promoters (% Holding)

61.25%

Mutual funds (% Holding)

0.00%

Non-Institution (% Holding)

38.75%

FI/Banks/Insurance (% Holding)

0.00%

Government (% Holding)

0.00%

FII

0.00%

About Ambani Orgochem Ltd.

Founded 1987
Managing Director Rakesh Shah
NSE Symbol AMBANIORGO

Peer Comparision

Stocks Name Market Cap (Cr)(₹) Market Price (₹) 52 Week Low-High (₹)
Asian Paints Ltd. 2,57,947.47 2,692.00 2,115.00 - 2,115.00
Solar Industries India Ltd. 1,67,050.52 18,400.00 11,646.00 - 11,646.00
Pidilite Industries Ltd. 1,59,324.90 1,560.55 1,259.00 - 1,259.00
SRF Ltd. 85,634.17 2,888.90 2,355.00 - 2,355.00
Coromandel International Ltd. 59,926.69 2,012.00 1,706.50 - 1,706.50
Berger Paints India Ltd. 57,565.56 495.50 391.10 - 391.10
The Fertilisers And Chemicals Travancore Ltd. 53,965.80 832.00 652.10 - 652.10
UPL Ltd. 52,034.60 616.40 563.15 - 563.15
Gujarat Fluorochemicals Ltd. 45,613.56 4,144.00 2,916.60 - 2,916.60
Godrej Industries Ltd. 44,979.72 1,328.60 744.20 - 744.20
no-content No Records Found

Latest News

Jul
18
2026
COMPANY Posted on Jul 18th 2026

Chembond Matl. Tech. - Quaterly Results

The sales for the June 2026 quarter moved up 28.72% to Rs. 629.69 millions as compared to Rs. 489.20 millions during the corresponding quarter last year.A comparatively good net profit growth of 42.05% to Rs. 45.03 millions was reported for the quarter ended June 2026 compared to Rs. 31.70 millions of previous same quarter.Operating Profit saw a handsome growth to 54.14 millions from 52.94 millions in the quarter ended June 2026.
(Rs. in Million)
  Quarter ended Year to Date Year ended
  202606 202506 % Var 202606 202506 % Var 202603 202503 % Var
Sales 629.69 489.20 28.72 629.69 489.20 28.72 2101.41 1712.07 22.74
Other Income 35.43 26.48 33.80 35.43 26.48 33.80 26.64 72.00 -63.00
PBIDT 54.14 52.94 2.27 54.14 52.94 2.27 150.03 203.42 -26.25
Interest 0.25 0.46 -45.65 0.25 0.46 -45.65 1.19 0.91 30.77
PBDT 53.89 52.48 2.69 53.89 52.48 2.69 137.14 217.98 -37.09
Depreciation 8.38 6.75 24.15 8.38 6.75 24.15 35.05 26.07 34.45
PBT 45.51 45.73 -0.48 45.51 45.73 -0.48 102.09 191.91 -46.80
TAX 0.48 14.03 -96.58 0.48 14.03 -96.58 24.51 19.67 24.61
Deferred Tax -7.54 5.44 -238.60 -7.54 5.44 -238.60 -14.69 -13.14 11.80
PAT 45.03 31.70 42.05 45.03 31.70 42.05 77.58 172.24 -54.96
Equity 67.24 67.24 0.00 67.24 67.24 0.00 67.24 67.24 0.00
PBIDTM(%) 8.60 10.82 -20.55 8.60 10.82 -20.55 7.14 11.88 -39.91
Read More
Jul
18
2026
COMPANY Posted on Jul 18th 2026

Tatva Chintan Pharma - Quaterly Results

A decent increase of about 34.37% in the sales to Rs. 1467.02 millions was observed for the quarter ended June 2026. The sales figure stood at Rs. 1091.80 millions during the year-ago period.The Total revenue for the quarter ended June 2026 of  Rs. 104.46  millions  grew by 103.51% from Rs. 51.33 millions.Operating profit surged to 280.58 millions from the corresponding previous quarter of 164.36 millions.
(Rs. in Million)
  Quarter ended Year to Date Year ended
  202606 202506 % Var 202606 202506 % Var 202603 202503 % Var
Sales 1467.02 1091.80 34.37 1467.02 1091.80 34.37 4962.96 3664.15 35.45
Other Income 40.33 13.69 194.59 40.33 13.69 194.59 35.28 35.61 -0.93
PBIDT 280.58 164.36 70.71 280.58 164.36 70.71 928.58 294.05 215.79
Interest 20.81 4.13 403.87 20.81 4.13 403.87 28.51 12.90 121.01
PBDT 246.59 160.23 53.90 246.59 160.23 53.90 900.07 281.15 220.14
Depreciation 105.65 89.69 17.79 105.65 89.69 17.79 368.42 276.54 33.22
PBT 140.94 70.54 99.80 140.94 70.54 99.80 531.65 4.61 11432.54
TAX 36.48 19.21 89.90 36.48 19.21 89.90 140.83 1.34 10409.70
Deferred Tax 36.48 7.09 414.53 36.48 7.09 414.53 40.16 1.32 2942.42
PAT 104.46 51.33 103.51 104.46 51.33 103.51 390.82 3.27 11851.68
Equity 233.92 233.92 0.00 233.92 233.92 0.00 233.92 233.92 0.00
PBIDTM(%) 19.13 15.05 27.05 19.13 15.05 27.05 18.71 8.03 133.15
Read More
Jul
18
2026
COMPANY Posted on Jul 18th 2026

Amal - Quaterly Results

An increase of about 87.09% to Rs. 267.54 millions in the topline was observed for the quarter ended June 2026. The topline stood at Rs. 143.00 millions during the similar quarter previous year.The Net Profit of the company vaulted to 1183.60% to Rs. 24.26  millions from Rs. 1.89 millions in the previous quarter.Operating profit surged to 37.47 millions from the corresponding previous quarter of 8.25 millions.
(Rs. in Million)
  Quarter ended Year to Date Year ended
  202606 202506 % Var 202606 202506 % Var 202603 202503 % Var
Sales 267.54 143.00 87.09 267.54 143.00 87.09 849.09 488.81 73.71
Other Income 1.17 1.96 -40.31 1.17 1.96 -40.31 6.38 6.18 3.24
PBIDT 37.47 8.25 354.18 37.47 8.25 354.18 87.80 115.51 -23.99
Interest 0.00 1.41 0.00 0.00 1.41 0.00 6.29 5.81 8.26
PBDT 37.47 6.84 447.81 37.47 6.84 447.81 81.51 109.70 -25.70
Depreciation 4.90 4.22 16.11 4.90 4.22 16.11 18.18 16.00 13.62
PBT 32.57 2.62 1143.13 32.57 2.62 1143.13 63.33 93.70 -32.41
TAX 8.31 0.73 1038.36 8.31 0.73 1038.36 17.95 24.95 -28.06
Deferred Tax 0.69 0.01 6800.00 0.69 0.01 6800.00 -0.01 -0.55 -98.18
PAT 24.26 1.89 1183.60 24.26 1.89 1183.60 45.38 68.75 -33.99
Equity 123.63 123.63 0.00 123.63 123.63 0.00 123.63 123.63 0.00
PBIDTM(%) 14.01 5.77 142.76 14.01 5.77 142.76 10.34 23.63 -56.24
Read More
Jul
17
2026
EQUITY Posted on Jul 17th 2026

Insecticides (India) informs about annual report and AGM

In continuation of letter no. IIL/SE/2026/2805/01 dated May 28, 2026, Insecticides (India) has informed that the 29th Annual General Meeting (AGM) of the Company is scheduled to be held on Wednesday, August 12, 2026 at 03:00 PM through Video Conferencing VC/OAVM. The Company is providing remote e-voting facility to all its members to cast their votes on all resolutions as set out in the Notice of the AGM. Remote e-voting period commences on Saturday, August 08, 2026 (9:00 am) and ends on Tuesday, August 11, 2026 (5:00 pm). The remote e-voting facility shall be disabled by CDSL for voting thereafter. During this period the members of the Company, holding shares either in physical form or in dematerialized form, as on the cut-off date i.e. August 05, 2026, only shall be entitled to avail the facility of remote e-voting. The details, such as, manner of registering/updating e-mail address, casting vote through e-voting, attending the AGM through VC/OAVM has been set out in the Notice of the 29th AGM. The Annual Report of FY 2025-26 containing Notice of 29th Annual General Meeting (Notice) and Business Responsibility and Sustainability Report for FY 2025-26 (BRSR) is being dispatched to the members by electronic mode and the same is hosted on the Company's website at the following web link: https://insecticidesindia.com/wp-content/uploads/2026/07/Annual-Report-25-26.pdf. The Annual Report of FY 2025-26 containing Notice and BRSR is attached.

The above information is a part of company’s filings submitted to BSE. 

Read More
Jul
17
2026
EQUITY Posted on Jul 17th 2026

Chemcrux Enterprises informs about updates on acquisition

Chemcrux Enterprises has informed that subsequent to intimation dated 14th May 2026 and pursuant to the provisions of the Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (herein after referred to as Listing Regulations), the wholly owned subsidiary of the Company has been incorporated under the name and style Chemcrux Foundation (as Section 8 Company) pursuant to the certificate of Incorporation issued by the Central Registration Centre, Registrar of Companies, received today i.e., 17th July 2026 at 02:54 pm. Further, the disclosure as required under SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, read with SEBI Master Circular dated 30th January 2026 is enclosed as Annexure- A.
The above information is a part of company’s filings submitted to BSE. 
Read More
no-content No Records Found

Sign in to Unlock Offers!

Explore Loans, Cards, Investments & Insurance

No SPAM We don't SPAM
Right Hand Side Image
STEP 1/2

Open Demat Account today!

+91

Enter mobile number

Invalid mobile number

Enter Full Name

Invalid Full Name

Verification required
close

Enter the One Time Password (OTP)

Sent to ********99

Edit Number
Enter valid OTP
Field should not be blank
You have exhausted your OTP attempts try again after 10 min

Request another in 60s

Resend OTP

secure   100% safe and secure

Frequently Asked Questions

What is the current share price of Ambani Orgochem Ltd. ?

The current share price of Ambani Orgochem Ltd. is ₹ as of .

The market capitalisation of Ambani Orgochem Ltd. is ₹101.93 as of 2026-06-30.

The 1-year return of Ambani Orgochem Ltd. is % as of .

The P/E ratio of Ambani Orgochem Ltd. is 0.00 as of 2026-07-18.

The 52-week high and low of Ambani Orgochem Ltd. are ₹143.90 and ₹94.90, respectively, as of .

The dividend yield of Ambani Orgochem Ltd. is 0.0% as of2026-06-30.

You can buy Ambani Orgochem Ltd. shares through a registered stockbroker or trading platform. Bajaj Markets partners with trusted brokers to help you open a demat account. This is the first step to trading, making it easier to invest in your desired shares.

The Managing Director of Ambani Orgochem Ltd. is Rakesh Shah.

When investing in a company’s stock, you may consider key factors such as its fundamentals, including financial health, historical performance, and growth potential. Assess the consistency of its performance, market conditions, and industry trends. Additionally, evaluate your own risk tolerance while reviewing aspects like quarterly earnings, management quality, and sector performance, for taking a well-informed decision.

You can track stock performance on online platforms through live market updates, historical charts, and news alerts. Regular analysis and stock alerts allow you to stay informed about significant price changes and events affecting the stock.

Common stock provides voting rights and the potential for dividends based on company performance, while in case of preferred stock, stockholders receive fixed dividends and have priority over common stockholders in asset distribution but generally lack voting rights.

Stock investments carry market risks, including price volatility, economic shifts, and sector-specific issues. Managing risk can involve diversifying your portfolio, setting stop-loss orders, and staying informed about market trends to make timely decisions.

Market capitalisation, or market cap, is the total value of a company’s outstanding shares and is calculated by multiplying the stock price by the total shares. It classifies companies as large-cap, mid-cap, or small-cap, reflecting their size, stability, and potential risk level in the stock market.

View More

Disclaimer

All content and research information displayed on the Site, are obtained from our partner Accord Fintech Private Limited. an authorized data feed vendor of BSE/NSE/MCX/NCDEX exchange. The data is provided on ‘As-Is’ basis and is not a live data feed but a feed with 15 minutes delay or more. Bajaj Markets does not warrant accuracy, completeness, timely availability of the information and data available on the Site. Past performance, when presented, is purely for reference purposes and is not a guarantee of similar future results.

The Services offered on the Site does not constitute investment advice in any manner whatsoever. You shall be solely responsible for any investment decisions made by placing reliance on the information provided on the Site.

Bajaj Markets partners with financial services entities for sourcing leads for services such as DEMAT accounts etc. In case you wish to avail the services, you shall be redirected to partners platform and shall be bound by the terms and conditions, privacy policy governing the said platform. 

Invalid Mobile Number

Invalid Full Name

Home
Home
ONDC_Shopping
Shopping
Loan
Loan Offers
My Accounts
My Accounts
Explore
Explore